The global knotless tissue control devices market is on a promising growth trajectory, with recent market research projecting a Compound Annual Growth Rate (CAGR) of 3.4% from 2022 to 2032. Valued at USD 465.6 million in 2022, the market is expected to soar to an impressive USD 672.6 million by 2032.
This substantial growth is primarily fueled by the rising demand for minimally invasive procedures and continuous technological advancements in the healthcare sector. Both healthcare providers and patients are increasingly gravitating toward minimally invasive techniques due to their significant benefits, including shorter recovery times and a reduced risk of complications. As a result, the demand for knotless tissue control devices has surged, marking a pivotal shift in modern medical practices.
Minimally invasive procedures have become the cornerstone of contemporary healthcare, offering patients the advantages of less pain, quicker recovery, and fewer post-surgical complications. Knotless tissue control devices play a vital role in these procedures by providing precise and reliable tissue manipulation without the need for traditional sutures. This technology not only enhances surgical outcomes but also significantly boosts patient satisfaction, driving its adoption in healthcare facilities across the globe.
Moreover, continuous technological advancements in knotless tissue control devices are propelling market growth. Innovations in device design and functionality are empowering surgeons to perform complex procedures with increased ease and accuracy. These advancements are not only improving surgical outcomes but also broadening the scope of procedures that can be performed using minimally invasive techniques.
As the global healthcare landscape evolves, the knotless tissue control devices market is poised for sustained growth. The increasing preference for minimally invasive procedures, coupled with ongoing technological innovations, is set to drive the market to unprecedented heights over the next decade.
The global knotless tissue control devices market is being driven by several key factors:
- Benefits of Knotless Tissue Control Devices: Knotless tissue control devices offer various benefits such as distributing tension along the wound, simplifying knot tying, and reducing knot-related complications. These advantages are expected to increase the demand for these devices in healthcare settings.
- Rising Number of Surgical Procedures: An increasing number of surgical procedures, including knee replacements, bypass surgeries, hip replacements, and cosmetic surgeries, are anticipated to drive the demand for knotless tissue control devices. As the population ages and the prevalence of conditions requiring surgical intervention rises, the demand for these devices is expected to grow correspondingly.
- Demographic Trends: The aging population is particularly relevant to the demand for knotless tissue control devices. A study published by the National Centre for Biotechnology Information indicates that approximately 30% of elderly individuals fall due to difficulties in walking, which often necessitates knee replacement surgeries. As the population continues to age globally, the need for such surgical procedures is expected to increase, further driving the demand for knotless tissue control devices.
- Technological Advancements and Product Innovation: The launch of efficient devices by key players in the market is expected to strengthen the industry. For example, Smith & Nephew launched HELICOIL knotless sutures in September 2020, which utilize bone marrow and associated stem cells to enhance the healing process. Such innovations enhance the effectiveness and usability of knotless tissue control devices, contributing to market growth.
Overall, the convergence of these factors is expected to fuel the growth of the global knotless tissue control devices market in the foreseeable future.
Gain Full Insight: Access the Complete Knotless Tissue Control Devices Market Report
Top of Form
Key Companies Profiled:
- Johnson & Johnson Services, Inc.
- Medtronic
- Ethicon US, LLC. (Subsidiary of Johnson & Johnson)
- Medline Industries, Inc.
Key Segments Profiled in the Global Knotless Tissue Control Devices Market:
By Product Type:
- Short-Term
- Long-Term
- Nonabsorbable Polymers
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Trauma Centers
- Medical Device Manufacturers
- Pharmaceutical Companies
- Research Centers and Laboratory
By Region:
- North American
- Latin American
- Western European
- Eastern European
- Asia-Pacific
- Japanese
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube